Prospective cohort study for changes of metabolic measures during antipsychotic treatments in patients with schizophrenia and bipolar disorder
Not Applicable
- Conditions
- Schizophrenia, Bipolar disorder
- Registration Number
- JPRN-UMIN000009868
- Lead Sponsor
- Department of Psychiatry, Hokkaido University Graduate School of Medicine
- Brief Summary
High baseline serum triglycerides and coexisting hypertension significantly predicted hyperglycemic progression in schizophrenia/ bipolar disorder patients treated with antipsychotics. Irrespective of the antipsychotic used, comprehensive longitudinal monitoring is essential in regular clinical practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients who are participating in an investigational drug study -Patients who have or had diabetes
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the frequency of subtypes based on monitoring guidance during one-year follow-up and difference in them among antipsychotics
- Secondary Outcome Measures
Name Time Method Relationship between metabolic deterioration and clinical measures, and difference in them among antipsychotics